Patients with HT were also characterized by an increased frequency of CD86+ non-classical Mo, which has been previously reported in patients with other autoimmune diseases including multiple sclerosis (37), systemic lupus erythematous (38), and primary biliary cirrhosis (39). Here, CD86 is linked to multiple sclerosis.